SPTBN1 and pancreatic neoplasm: Indeed, in a proteomics study of 55 pancreatic cancer patients, lower levels of SPTBN1 correlate with advanced PDAC stage and worse prognosis [47], and similar data were reported in a cohort of 82 resected PDAC patients [48] (Figure S3D).